Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Niramas Utama Tbk. (JELI) vs Merck Tbk. (MERK) Price & Performance

Niramas Utama Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Niramas Utama Tbk. vs Merck Tbk. — how do they compare? Niramas Utama Tbk. trades at Rp1,005 (market cap 1.31T, 64.48M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Niramas Utama Tbk. is more actively traded (64.48M versus 37.6K). Which is the better fit depends on your goals.

JELIMERK
Market Cap
1.31T1.7T
Volume
64.48M37.6K
Lot
644.81K376
Turnover
65.83B144.47M
Average Price
1,020.913,842.23
Value
65.83B144.47M
Indicative Equilibrium Price
1,0053,840
Indicative Equilibrium Volume
24.22K7

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JELI
View details
MERK
View details

About Niramas Utama Tbk.

PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama

Read more on JELI

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK